DalsnaFinance

IN

Inhibrx Biosciences Inc $INBX

Health Care

Russell 2000

Create a scorecard

Live price temporarily unavailable.

Price history

Loading chart…

Inhibrx Biosciences Inc (INBX) is a Health Care company in the Russell 2000. Latest news and coverage below.

IPO: August 19, 2020 · $17.00 offering · NASDAQ · View IPO details →

Recent News (1)

Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study PR Newswire · 04 Sep 2026 – Event to be webcast live on Tuesday, September 8 th at 5:00 a.m. PT – SAN DIEGO, Sept. 4, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage…

More Health Care stocks

Browse all companies →